Cargando…
Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view
Pharmacogenomic biomarker availability of Hungarian Summaries of Product Characteristics (SmPC) was assembled and compared with the information in US Food and Drug Administration (FDA) drug labels of the same active substance (July 2019). The level of action of these biomarkers was assessed from The...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253355/ https://www.ncbi.nlm.nih.gov/pubmed/31787752 http://dx.doi.org/10.1038/s41397-019-0123-z |